Metffil VG 2mg/500mg/0.3mg Tablet
Marketer
Fourrts India Laboratories Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Metffil VG 2mg/500mg/0.3mg Tablet
Diabex Trio 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex Trio should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage adjustments will be determined by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to effective diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Learn to recognize these signs and carry readily available glucose sources, like sugary snacks or juice, to counter low blood sugar. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Metffil VG 2mg/500mg/0.3mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Metffil VG 2mg/500mg/0.3mg Tablet
Managing Type 2 Diabetes
Major Benefits of Metffil VG 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Metffil VG 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer the tablet on an empty stomach.
Common Side effects of Metffil VG 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metffil VG 2mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metffil VG 2mg/500mg/0.3mg tablet whole; do not break, crush, or chew it. Administer on an empty stomach.
How Metffil VG 2mg/500mg/0.3mg Tablet works:
Each Metffil VG 2mg/500mg/0.3mg tablet contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Metffil VG 2mg/500mg/0.3mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metffil VG 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Metffil VG 2mg/500mg/0.3mg Tablet use are likely incompatible. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Metffil VG 2mg/500mg/0.3mg tablets pose a likely risk for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Moreover, this medication is unsuitable for those with advanced kidney disease.
LiverCAUTION
Individuals with liver impairment should use Metffil VG 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Metffil VG 2mg/500mg/0.3mg Tablet :
Should you forget a Metffil VG 2mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metffil VG 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently